AnilVachaniMD
Pulmonology • Philadelphia, PACritical Care Medicine, Pleural Disease
Assistant Professor, Medicine, Perelman School of Medicine
Dr. Vachani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Fl 1
Philadelphia, PA 19104Phone+1 215-662-3202Fax+1 215-349-8432
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003- University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1999
University of California San Francisco School of MedicineClass of 1996
Certifications & Licensure
PA State Medical License 1997 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Early Diagnosis of Pulmonary Nodules Start of enrollment: 2012 Oct 01
- DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules Start of enrollment: 2013 Jan 01
- DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer Start of enrollment: 2011 Sep 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsEconomic Value of Bronchoscopy Technologies that Improves Sensitivity for Malignancy for Peripheral Pulmonary Lesions.David E Ost, Fabien Maldonado, Jason Shafrin, Jaehong Kim, Moises A Marin
Annals of the American Thoracic Society. 2024-12-01 - 4 citationsClinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection.Peter J Mazzone, Peter B Bach, Jacob Carey, Caitlin A Schonewolf, Katalin Bognar
Cancer Discovery. 2024-11-01 - Clinical utility of an artificial intelligence radiomics-based tool for risk stratification of pulmonary nodules.Roger Y Kim, Clarisa Yee, Sana Zeb, Jennifer Steltz, Andrew J Vickers
JNCI Cancer Spectrum. 2024-09-02
Journal Articles
- A Gene Expression Classifier from Whole Blood Distinguishes Benign from Malignant Lung Nodules Detected by Low-Dose CTAnil Vachani, William N Rom, Gerard Criner, Harvey Pass, Clinical Cancer Research
Press Mentions
AI Program Accurately Diagnoses Common Lung Cancer from Tissue ImagesJune 11th, 2024- Optellum's Clinical Partners Present at ATS International Conference 2023May 19th, 2023
- Penn Medicine Lands $5.7M NCI Grant for Telehealth Research CenterAugust 19th, 2022
- Join now to see all
Grant Support
- Peripheral Blood Gene Expression For The Diagnosis Of Indeterminate Lung NodulesNational Cancer Institute2011
- Molecular Epidemiology Of Lung CancerNational Cancer Institute2006–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
